It’s pretty lame, I have to admit, but it’s Monday and I’m just coming back from a bad shaking up I got from a bike accident. I don’t think this blog has been doing enough to cover the widening scandal of ghosted articles in the medical literature. We talk about it among ourselves, the librarians I mean, and there is an active discussion among some faculty here, but over all, I feel I’ve let the side down somehow. So, it’s time to redress the balance, and we’ll start by bringing to our readers’ attention a story that ran in the New York Times of Friday last, in the Business section. The paper is running a series of articles on the topic of ghostwritten articles in medical journals. Ghosted articles are those written at the behest of a drug company, by a firm of “medical educators”, and then circulated to some “key opinion leaders” in the field, with the suggestion that they review and submit these articles for publication under their names, and receive a suitable expression of corporate gratitude for their cooperation. Nobody knows for sure how many such articles are in the medical literature, serving as the basis for research efforts and patient care decisions. But, the orotund Latin phrase non pauci, not a few, comes to mind. Well, there are some “issues” here, as they say, and I don’t want to review the whole topic in this post. I do want to highlight one reaction to the whole mess by one editor of a major journal, Dr. Cynthia E. Dunbar, editor in chief of BLOOD. In brief, her response is “get rid of them”, and perhaps bar the submitting author from furter publication in the journal, at least for a period of years. Needless to say, such action would also lead to considerable bad odor in whatever professional community we happening to be discussing, so it’s a pretty big stick. Journal editors have been accused of being too wussy on the question of “undisclosed contributions”, let’s call them. So the BLOOD action ups the ante quite a bit. PLoS Medicine has also suggested a stance of zero tolerance on ghosting. And Sen. Grassley of Iowa has been after journals to see what kind of policies they have on the matter and is not really satisfied with the replies. My own idea is to ask the National Library of Medicine to introduce a new publication type, Advertisement, and then request that this be applied to any discovered ghosted article. The withdrawal problem would take care of itself, as authors begged to have their offending articles withdrawn. Who, after all, wants to be unveiled as a corporate shill?
The Times piece has several internal links which are worth following:
Bloody Ghosts